BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 14960630)

  • 1. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.
    Kyuma M; Nakata T; Hashimoto A; Nagao K; Sasao H; Takahashi T; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2004 Feb; 45(2):155-63. PubMed ID: 14960630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
    Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.
    Wakabayashi T; Nakata T; Hashimoto A; Yuda S; Tsuchihashi K; Travin MI; Shimamoto K
    J Nucl Med; 2001 Dec; 42(12):1757-67. PubMed ID: 11752070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients.
    Gerson MC; Caldwell JH; Ananthasubramaniam K; Clements IP; Henzlova MJ; Amanullah A; Jacobson AF
    Circ Cardiovasc Imaging; 2011 Mar; 4(2):87-93. PubMed ID: 21193691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts.
    Nakata T; Miyamoto K; Doi A; Sasao H; Wakabayashi T; Kobayashi H; Tsuchihashi K; Shimamoto K
    J Nucl Cardiol; 1998; 5(6):579-90. PubMed ID: 9869480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
    Doi T; Nakata T; Yuda S; Hashimoto A
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):74-83. PubMed ID: 28158459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction.
    Nakata T; Wakabayashi T; Kyuma M; Takahashi T; Hashimoto A; Ogata H; Tsuchihashi K; Shimamoto K
    J Card Fail; 2003 Apr; 9(2):113-21. PubMed ID: 12751132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
    Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
    Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹²³I-MIBG Imaging for Prediction of Mortality and Potentially Fatal Events in Heart Failure: The ADMIRE-HFX Study.
    Narula J; Gerson M; Thomas GS; Cerqueira MD; Jacobson AF
    J Nucl Med; 2015 Jul; 56(7):1011-8. PubMed ID: 26069309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac sympathetic denervation and ongoing myocardial damage for prognosis in early stages of heart failure.
    Arimoto T; Takeishi Y; Niizeki T; Nozaki N; Hirono O; Watanabe T; Nitobe J; Tsunoda Y; Suzuki S; Koyama Y; Kitahara T; Okada A; Takahashi K; Kubota I
    J Card Fail; 2007 Feb; 13(1):34-41. PubMed ID: 17339001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.
    Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Heart; 2006 May; 92(5):625-30. PubMed ID: 16159967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation of mortality risk charts using 123I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk models.
    Nakajima K; Nakata T; Matsuo S; Jacobson AF
    Eur Heart J Cardiovasc Imaging; 2016 Oct; 17(10):1138-45. PubMed ID: 26705487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial
    Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.
    Merlet P; Benvenuti C; Moyse D; Pouillart F; Dubois-Randé JL; Duval AM; Loisance D; Castaigne A; Syrota A
    J Nucl Med; 1999 Jun; 40(6):917-23. PubMed ID: 10452306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic role of brain natriuretic peptides in hemodialysis patients.
    Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
    Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.
    Takami Y; Horio T; Iwashima Y; Takiuchi S; Kamide K; Yoshihara F; Nakamura S; Nakahama H; Inenaga T; Kangawa K; Kawano Y
    Am J Kidney Dis; 2004 Sep; 44(3):420-8. PubMed ID: 15332214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.